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Caseload in relation to outcome has been a topic of an increasing number of publications in the medi-cal literature. Hospital volume and outcome are 
generally more strongly associated for medical conditions 
that require more complex management.15,35 Regulations 
for centralization of specialized care are emerging from 
the medical field, government, and health insurance com-
panies. For treatment of patients with ruptured cerebral 
aneurysms, a complex disease, several studies with con-
trasting results have appeared.6,7,16 The purpose of this 
study was to perform a meta-analysis to investigate the 
relationship between caseload and outcome in series of 
patients undergoing treatment of aneurysms after sub-
arachnoid hemorrhage (SAH). The treatment modality 
could be either clipping or coiling. Hospital mortality was 
chosen as the outcome measure.
Methods
The meta-analysis was constructed according to the 
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Object. Increasing evidence exists that treatment of complex medical conditions in high-volume centers is found 
to improve outcome. Patients with subarachnoid hemorrhage (SAH), a complex disease, probably also benefit from 
treatment at a high-volume center. The authors aimed to determine, based on published literature, whether a higher 
hospital caseload is associated with improved outcomes of patients undergoing treatment after aneurysmal subarach-
noid hemorrhage.
Methods. The authors identified studies from MEDLINE, Embase, and the Cochrane Library up to September 
28, 2012, that evaluated outcome in high-volume versus low-volume centers in patients with SAH who were treated 
by either clipping or endovascular coiling. No language restrictions were set. The compared outcome measure was 
in-hospital mortality. Mortality in studies was pooled in a random effects meta-analysis. Study quality was reported 
according to the GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria.
Results. Four articles were included in this analysis, representing 36,600 patients. The quality of studies was 
graded low in 3 and very low in 1. Meta-analysis using a random effects model showed a decrease in hospital mortal-
ity (OR 0.77 [95% CI 0.60–0.97]; p = 0.00; I2 = 91%) in high-volume hospitals treating SAH patients. Sensitivity 
analysis revealed the relative weight of the 1 low-quality study. Removal of the study with very low quality increased 
the effect size of the meta-analysis to an OR of 0.68 (95% CI 0.56–0.84; p = 0.00; I2 = 86%). The definition of hospital 
volume differed among studies. Cutoffs and dichotomizations were used as well as division in quartiles. In 1 study, 
low volume was defined as 9 or fewer patients yearly, whereas in another it was defined as fewer than 30 patients 
yearly. Similarly, 1 study defined high volume as more than 20 patients annually, and another defined it as more than 
50 patients a year. For comparability between studies, recalculation was done with dichotomized data if available. 
Cross et al., 2003 (low volume ≤ 18, high volume ≥ 19) and Johnston, 2000 (low volume ≤ 31, high volume ≥ 32) 
provided core data for recalculation. The overall results of this analysis revealed an OR of 0.85 (95% CI 0.72–0.99; 
p = 0.00; I2 = 87%).
Conclusions. Despite the shortcomings of this study, the mortality rate was lower in hospitals with a larger case-
load. Limitations of the meta-analysis are the not uniform cutoff values and uncertainty about case mix.
(http://thejns.org/doi/abs/10.3171/2013.9.JNS13640)
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Abbreviations used in this paper: GRADE = Grading of Rec-
ommendations Assessment, Development and Evaluation; SAH = 
subarachnoid hemorrhage.
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MOOSE (meta-analysis of observational studies in epi-
demiology) guidelines.37 An independent experienced li-
brarian searched the literature published in MEDLINE, 
Embase, and the Cochrane Library through September 
28, 2012, using the following key words: SAH, case load, 
outcome, aneurysm. No language restrictions were used. 
For a detailed search string please see Table 1. Studies 
were eligible for inclusion if they met the following cri-
teria: 1) evaluated in-hospital mortality after open and/or 
endovascular treatment in patients with ruptured intracra-
nial aneurysms, 2) compared low-volume with high-vol-
ume hospitals, and 3) provided an odds ratio or core data 
to calculate an odds ratio. If the same data were used in 
more than one article, the most recent or largest data set 
was included. Duplicate papers were removed. Conference 
abstracts, reviews, editorials, meta-analyses, and animal 
studies were also excluded. Studies were excluded if they 
did not provide postoperative mortality rates in patients 
treated for ruptured aneurysms with endovascular coiling 
or surgical clipping in relation to volume. Two research-
ers (M.v.A. and H.D.B.) independently reviewed the titles 
and abstracts of the articles. In the case of disagreement 
during this process, a third reviewer (J.d.V.) was asked. 
From the remaining articles, full-text versions were ob-
tained and were independently evaluated by the same re-
searchers. From the full-text versions, reference screening 
was performed to evaluate other possible studies. A data 
recording form, developed for this purpose, was used by 
2 authors (M.v.A. and R.B.) for independent data extrac-
tion from each study. After extraction, data were reviewed 
and were compared by the first author. Disagreement was 
solved by consensus. Assessment of the methodological 
quality of the studies included in the review was done ac-
cording to the GRADE guidelines.14 The studies were in-
dependently assessed by the 2 researchers (R.B. and J.d.V.) 
for limitations, indirectness, inconsistency, imprecision, 
and publication bias. Overall in-hospital mortality after 
open surgical and/or endovascular treatment in patients 
with SAH was defined as the primary end point.
Statistical Analysis
To identify potential associations between hospital 
volume and mortality, a pooled odds ratio with 95% con-
fidence intervals was constructed. The significance of the 
overall odds ratio was determined by the z-test. The Type 
I error was set at 0.05. The tests were 2-tailed. The ran-
dom effects model was used as the preferable approach 
to manage potential between-study heterogeneity. Statisti-
cal heterogeneity across studies was quantified using the 
I2 statistic. This statistic describes the percentage of total 
variation across studies that is due to heterogeneity rather 
than chance.19 The I2 statistic was calculated from Q (the 
Cochran heterogeneity statistic) as follows: I2 = 100% × 
TABLE 1: Search strategy and results of MEDLINE, Embase, and Cochrane Library searches*
No. of Studies
Step Search PubMed Cochrane Embase
 1 subarachnoid hemorrhage[MeSH:noexp] 14,980 375 26,035
 2 subarachnoid haemorrhage[tiab] OR (subarachnoid[tiab] AND hemorrhage[tiab]) OR subarachnoid hemor- 
 rhage[tiab] OR subarachnoid haemorrhages[tiab] OR subarachnoid hemorrhages[tiab] OR SAH[tiab] OR 
 SAHs[tiab] OR subarachnoid hematoma[tiab] OR subarachnoid bleeding[tiab]
17,916 930 22,474
 3 Step 1 OR Step 2 22,212 1,214 31,404
 4 intracranial aneurysm[MeSH] 19,901 333 23,962
 5 (brain aneurysm[tiab] OR brain aneurysms[tiab] OR cerebral aneurysm[tiab] OR cerebral aneurysms[tiab]) 4,006 372 5,034
 6 Step 4 OR Step 5 20,790 492 30,331
 7 rupture*[tiab]† 86,436 2,304 102,580
 8 Step 6 AND Step 7 5,423 193 4,981
 9 Step 3 OR Step 8 24,675 985 33,626
10 “neurosurgery/statistics and numerical data”[MeSH]‡ 1,923 13 964
11 workload[MeSH] 13,778 487 24,873
12 high volume[tiab] OR high volumes[tiab] OR high-volume[tiab] OR higher volume[tiab] OR higher volumes[tiab] 
 OR low volumes[tiab] OR lower volumes[tiab] OR low-volume[tiab] OR lower-volume[tiab] OR workload[tiab] 
 OR (work[tiab] AND load[tiab]) OR caseload[tiab] OR caseloads[tiab] OR surgeon volume[tiab] OR work- 
 loads[tiab] OR surgical volume[tiab] OR operative volume[tiab] OR surgical volumes[tiab] OR operative vol- 
 umes[tiab] OR (case[tiab] AND load[tiab]) OR case volume[tiab] OR case volumes[tiab] OR operation rate 
 [tiab] OR operation rates[tiab] OR hospital volume[tiab] OR hospital volumes[tiab] OR highest-volume[tiab] 
 OR highest-volumes[tiab]
42,833 24,767 56,421
13 Step 10 OR Step 11 OR Step 12 54,269 24,778 71,050
14 Step 9 AND Step 13 76 35 152
* MeSH = Medical Subject Headings; noexp = no explosion of MeSH heading; tiab = title/abstract.
†  The asterisk in this field indicates that rupture was a major topic of these articles.
‡ Quotation marks indicate that the entire phrase was searched.
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(Q - df)/Q. For sensitivity analysis, each study was re-
moved in turn from the total, and the remaining studies 
were reanalyzed to identify the impact of each study on 
the overall result. Publication bias was graphically as-
sessed using a funnel plot. In addition, Egger’s test was 
used for quantitative assessment. Comprehensive Meta-
Analysis software (version 2.2.046, BIOSTAT) was used 
for statistical analysis.
Results
Included Studies
The initial search revealed 263 studies (Table 1). Af-
ter removing duplicate studies, abstracts from 211 studies, 
including one found by reference screening,36 were evalu-
ated. One hundred seventy-nine studies were excluded be-
cause they did not meet inclusion criteria. Thirty-two stud-
ies were considered for full-text evaluation.1–13,16–18,20–23, 
25–27,30–34,36,38–40 Twenty-eight studies were excluded for the 
following reasons: 2 were review studies,34,40 5 had insuffi-
cient data,5,8,10,36,39 3 included treatment of unruptured an-
eurysms,3,21,33 8 contained single-center data,4,6,11–13,22,30,31 3 
had no caseload comparison,18,25,26 2 did not have mortali-
ty as an outcome,1,20 1 was an editorial,17 3 had overlapping 
source data,2,7,32 and 1 included only patients older than 
65 years.38 Therefore, 4 studies were included for final 
analysis (Fig. 1).9,16,23,27 The selected studies involved a to-
tal of 36,600 patients. Retrospective data from databases 
were used in 3 studies, and 1 evaluated data from a survey 
(Table 2). The treatment modality was clipping or endo-
vascular coiling in 3 studies, and 1 study only evaluated 
open surgical results. Hospital volume definitions differed 
between studies. Cutoffs and dichotomizations were used 
as well as division in quartiles. Low volume was defined 
as 9 or fewer patients yearly in 1 study and as fewer than 
30 in another. Similarly, high volume was defined as more 
than 20 patients annually in 1 study and as more than 50 
patients annually in another. The definitions used in the 
articles were used for primary analysis. The methodologi-
cal quality of 3 articles was graded as low and 1 as very 
low. Up-rating was not performed (Table 3).
Meta-Analysis
The overall meta-analysis suggested a significant re-
lationship for in-hospital mortality for SAH patients in fa-
vor of high-volume hospitals (OR 0.77 [95% CI 0.60–0.97] 
random model) (Fig. 2A). The Q value for the test of het-
erogeneity was 33.2 (p = 0.0001), indicating heterogeneity 
and justifying the use of the random effects analysis. The 
Fig. 1. Chart showing the results of the literature search.
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sensitivity analysis revealed a relative weight of the study 
by Hattori et al.16 Including this study and subsequently 
removing others by alternation lifted the point estimate 
slightly upward. The result was not statistically signifi-
cant. However, removal of this study with very low quality 
(see Table 3) increased the effect size to an OR 0.68 (95% 
CI 0.56–84) (Fig. 2B).7 The funnel plot suggested publica-
tion bias; however, the Egger’s test (intercept 1.21, p = 0.86 
[2-tailed]) did not (Fig. 3). This result should be interpret-
ed with great caution, because of the very limited number 
of studies. For comparability between studies, recalcula-
tion was done with dichotomized data if available (Table 
4). Cross et al. (low volume ≤ 18 patients, high volume ≥ 
19 patients) and Johnston (low volume ≤ 31 patients, high 
volume ≥ 32 patients) provided core data for recalcula-
tion.9,23 The overall results of this analysis of the 4 studies 
revealed an OR of 0.85 (95% CI 0.72–0.99).
Discussion
This meta-analysis demonstrates that treatment of pa-
tients with ruptured intracranial aneurysms in high-vol-
ume centers is associated with lower in-hospital mortality 
compared with low-volume centers. The positive corre-
lation between a high-volume center and outcome could 
be attributed to several factors. First of all, high-volume 
centers more likely have a subspecialized team working 
in a multidisciplinary setting. A well-functioning and ex-
perienced team consisting of neurologists, neurosurgeons, 
neuroradiologists, neurointerventionalists, neurorehabili-
tation specialists, neurointensivists, and a dedicated nurs-
ing team will certainly contribute to a better outcome.5,8,24 
A potential drawback of centralization would be the risk 
of rehemorrhage and death during transfer; however, as 
investigated by Bardach et al., the organization of SAH 
care in high-volume hospitals is justified not only for cost-
effectiveness but also for patient outcome.1
Several limitations of this study should be mentioned. 
First, the study data mainly rely on retrospective data 
based on hospital coding and can therefore be biased. 
Second, the patients within the studies were a selection 
of a population mainly from northern US databases. In-
frastructural and geological characteristics might not be 
applicable to other countries. Third, the treatment modal-
ity might be associated with outcome and with hospital 
volume; centers also providing endovascular treatment 
have better results because of the lower associated morbid-
ity and mortality rates as found in the International Sub-
arachnoid Aneurysm Trial (ISAT) and recently the Bar-
row Ruptured Aneurysm Trial (BRAT).28,29 High-volume 
centers are more likely to have an endovascular treatment 
modality and thus will probably have better results.9,13 
Fourth, we used unadjusted core data from the studies to 
attain comparability, since adjustment for case mix was 
not done or it was done in different ways. Hattori et al. 
corrected for initial clinical grade, but not for comorbidi-
ties and did not find a significant difference in the distri-
bution of the World Federation of Neurosurgical Societies 
grade on admission between the different volume groups.16 
Cross et al. corrected for comorbidities but not for initial 
grade.9 Leake et al. did not correct for comorbid conditions 
nor initial grade.27 Johnston corrected for age but not for 
comorbidities or initial grade.23 Fifth, the distinction be-
tween low volume and high volume is artificial. As shown, 
a uniform cutoff is not provided. At best, an approximate 
cutoff could be estimated. However, recalculation with 
dichotomized data revealed comparable results, center-
ing the possible distinction between high volume and low 
volume around 20–30 patients yearly. Sixth, in-hospital 
mortality was chosen as the primary outcome measure; 
although commonly used as a measure of quality of care, 
it can be influenced by discharge policies. Better would 
be a more detailed outcome measure such as the modi-
fied Rankin Scale score; unfortunately, only the study by 
Hattori et al. provided these data.16 Finally, transfer of pa-
TABLE 2: Characteristics of the studies
Definition of Vol
Authors & Year Source, Years Treatment modality Low High
Johnston, 2000 University Health Systems Consortium, 
 1994–1997
clipping & coiling 0–16 (1st quartile) >45 (4th quartile)
Cross et al., 2003 database (California & Florida), 1998–2000 clipping & coiling 0–9 (1st quartile) 36–158 (4th quartile)
Hattori et al., 2007 Survey Japan, 2003 clipping <30 (1st group) ≥50 (3rd group)
Leake et al., 2011 Nationwide Inpatient Sample (NIS) database, 
 2001–2008
clipping & coiling ≤20 >20
TABLE 3: GRADE evidence profile
Authors & Year Study Design Limitations Inconsistency Indirectness Imprecision Publication Bias Magnitude of Effect Quality
Johnston, 2000 observational none none none none none none low
Cross et al., 2003 observational none none none none none none low
Hattori et al., 2007 observational serious none none none none none very low
Leake et al., 2011 observational none none none none none none low
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tients might cause bias. Patients who were likely to die 
were not transferred to a high-volume center for treatment; 
conversely, transferred patients tended to do better than 
patients in community hospitals.13,41
This study does not answer the question of how much 
patients should be treated by a single surgeon or neuroin-
terventionalist to obtain the best result.3,26,39 As previously 
stated, the results of treatment are not merely the merits of 
one specialist but the chain of care. In the scope of qual-
ity of care and the increasing demand for centralization, 
volume number alone is not sufficient as a parameter to 
guide these developments. Caseload should be seen as one 
of the cofactors related to outcome.
Conclusions
Despite shortcomings of the included studies but 
based on the best available data at this moment, mortality 
is lower in hospitals that treat a high volume of patients 
with SAH. Although a true cutoff value to distinguish be-
tween high- and low-volume centers could not be given, 
it probably can be centered between 20 and 30 patients 
annually. An explanation for the relationship between out-
come and caseload could be a multidisciplinary approach 
resulting in a team dedicated to the care of patients with 
SAH. As such, the number of treated patients yearly can-
not be used as a sole measure for quality of care.
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Fig. 2. Forest plots showing results of the meta-analysis of high versus low volume hospitals (A) and sensitivity analysis (B). 
The squares indicate the mean, the whiskers indicate the 95% CI, and the diamonds indicate the pooled estimate (the width of 
the diamond represents the 95% CI).
Fig. 3. Funnel plot. The points correspond to the treatment effects 
from individual studies, the diagonal lines show the expected 95% con-
fidence intervals around the summary estimate. Odds ratios are plotted 
on a logarithmic scale.
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